全文获取类型
收费全文 | 651篇 |
免费 | 66篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 41篇 |
妇产科学 | 10篇 |
基础医学 | 59篇 |
口腔科学 | 21篇 |
临床医学 | 120篇 |
内科学 | 155篇 |
皮肤病学 | 40篇 |
神经病学 | 15篇 |
特种医学 | 102篇 |
外科学 | 70篇 |
综合类 | 12篇 |
预防医学 | 22篇 |
眼科学 | 3篇 |
药学 | 11篇 |
肿瘤学 | 44篇 |
出版年
2023年 | 8篇 |
2022年 | 2篇 |
2021年 | 6篇 |
2020年 | 5篇 |
2019年 | 9篇 |
2018年 | 16篇 |
2017年 | 15篇 |
2016年 | 25篇 |
2015年 | 18篇 |
2014年 | 32篇 |
2013年 | 29篇 |
2012年 | 15篇 |
2011年 | 21篇 |
2010年 | 31篇 |
2009年 | 50篇 |
2008年 | 17篇 |
2007年 | 18篇 |
2006年 | 21篇 |
2005年 | 17篇 |
2004年 | 14篇 |
2003年 | 12篇 |
2002年 | 7篇 |
2001年 | 7篇 |
2000年 | 3篇 |
1999年 | 11篇 |
1998年 | 33篇 |
1997年 | 34篇 |
1996年 | 36篇 |
1995年 | 26篇 |
1994年 | 24篇 |
1993年 | 29篇 |
1992年 | 6篇 |
1991年 | 6篇 |
1990年 | 7篇 |
1989年 | 15篇 |
1988年 | 12篇 |
1987年 | 19篇 |
1986年 | 11篇 |
1985年 | 8篇 |
1984年 | 7篇 |
1983年 | 5篇 |
1982年 | 3篇 |
1981年 | 9篇 |
1980年 | 5篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1963年 | 2篇 |
排序方式: 共有726条查询结果,搜索用时 15 毫秒
81.
Bangert BA; Modic MT; Ross JS; Obuchowski NA; Perl J; Ruggieri PM; Masaryk TJ 《Radiology》1995,195(2):437
82.
83.
84.
85.
Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects 总被引:2,自引:0,他引:2
Benoît Larivière MSc ; Michèle Rouleau PhD ; Sylvain Picard MT ; André D. Beaulieu MD FRCPC 《Wound repair and regeneration》2003,11(1):79-89
Integrin-mediated cell adhesion and growth factor stimuli are both required for optimal control of cell proliferation. In the context of skin injury, cell-derived fibronectin and platelet-derived growth factor play important roles in the stimulation of cell proliferation and migration, activities that are crucial to the healing process. To assess the ability of exogenously supplied plasma-derived fibronectin to stimulate wound repair and to study its ability to cooperate with platelet-derived growth factor-BB during healing, we devised a novel topical delivery formulation that allows the controlled release of both molecules to a wound. Using this topical formulation and the rabbit ear model of dermal wound healing, we show that plasma fibronectin is a potent stimulator of the wound healing process. We also show that administration of fibronectin and platelet-derived growth factor-BB in combination has additive wound healing effects. Finally, we report novel findings on the ability of soluble plasma fibronectin to potentiate the mitogenic effects of platelet-derived growth factor-BB in vitro. These findings not only show that optimal concentrations of exogenous fibronectin administered using an effective delivery system stimulate wound healing; they also suggest that PDGF-BB should be administered with fibronectin to achieve optimal therapeutic stimulation of wound healing. 相似文献
86.
JA Gómez Gerique A Porres D López Martinez LA Alvarez Sala E Blazquez MT Montoya M De Oya 《Acta paediatrica (Oslo, Norway : 1992)》1996,85(1):38-42
Increased plasma lipoprotein(a)-Lp(a)-levels are linked to a high risk of cardiovascular disease unrelated to other lipoproteins. It seems that Lp(a) values in childhood remain unaltered up to adulthood. In a randomly chosen population of 1970 children, aged from 4 to 18 years and living in a Spanish community, the following serum parameters were studied: total cholesterol, total triglycerides, Lp(a), high-density lipoprotein cholesterol and low-density lipoprotein cholesterol. Mean Lp(a) serum values were 15.0 ± 14.7mg dl-1 . No differences were seen between either sex in the first years of childhood. Of the studied children, 15.1% presented Lp(a) concentrations above 30 mg dl-1 . A correlation between Lp(a) and total cholesterol concentrations, which disappeared when low-density lipoprotein cholesterol concentrations were corrected according to cholesterol present in Lp(a), was observed. 相似文献
87.
Mohammed M. Dar AB Zeinab Abdel-Wahab PhD Carol E. Vervaert MT Tim Darrow PhD Jack Barber PhD Dr. H. F. Seigler MD 《Annals of surgical oncology》1996,3(3):247-254
Background: Recent studies have demonstrated the usefulness of gene-modified tumor cells for immunotherapy. Using the tumorigenic murine
fibrosarcoma, MCA 106, we investigated the effects of localized interferon-γ (IFNg) secretion on tumorigenicity and on long-term memory.
Methods: The murine IFNg (MuIFNg) gene was introduced into tumor cells. High and low IFNg-secreting clones were isolated. C57BL/6
mice were injected subcutaneously (s.c.) with either parental (P), high or low IFNg-secreting (H- or L-IFNg) cells, and tumor
growth was assessed weekly. Spleens were harvested on different days postinjection (p.i.) to assess in vitro cytolytic activity.
In parallel, tissues from injection sites were stained with macrophage-, CD4-, and CD8-detecting antibodies. Mice were injected
s.c. with H-IFNg MCA106 tumor. After 150 days the animals were rechallenged s.c. with MCA106P in one leg and with irrelevant
syngeneic tumor in the other.
Results: Both P- and L-IFNg cells had similar growth, whereas the H-IFNg cells never grew. Only splenocytes from the H-IFNg animals
showed in vitro CTL activity persisting until day 30 p.i. Histological data revealed a macrophage and CD4+ infiltrate much earlier in the H-IFNg group compared with the P group. Only the irrelevant, syngeneic tumor grew in animals
previously injected with H-IFNg cells, whereas both P and irrelevant syngeneic tumors grew in controls.
Conclusions: Transduction of MCA106 cells with the MuIFNg gene diminished in vivo tumorigenicity in proportion to the amount of IFNg secreted.
Immunization with H-IFNg cells elicited a host response characterized by macrophages and CD4+ cells. Long-term tumor-specific memory was seen after immunization with H-IFNg cells. 相似文献
88.
89.
Determination of Proliferation Index By MIB-1 Immunostaining in Early Stage Breast Cancer Using Quantitative Image Analysis 总被引:1,自引:0,他引:1
Lester J. Layfield M.D. Billie-Jo M. Kerns B.S. MT Debbi H. Conlon. A.A.S. HT J. Dirk Iglehart M.D. † Jeffrey R Marks PhD † Richard K. Dodge M.S. ‡ 《The breast journal》1995,1(6):362-371
Abstract: Several clinicopathologic variables influence prognosis in breast cancer, including stage, histologic grade, nodal status, and tumor size. Multiple studies have shown an independent value of proliferation index as a prognostic variable for the stratification into favorable and unfavorable groups. The monoclonal antibody MIB-1 reacts with the same antigen site, not epitope, as recognized by the Ki-67 antibody. Like Ki-67, MIB-1 reacts with cells in the late G1, S, M and G2 phases of the cell cycle, but MIB-1 has the advantage of reacting with formalin-fixed, paraffin-embedded material. The authors investigated the feasibility of using image analysis to quantitate the MIB-1 antibody staining (proliferation index [PI]) and predict survival in a series of 230 patients with stage I and stage II breast cancer. In a univariate Cox regression model, larger values of MIB-1 were related to shorter survival times (p < 0.001). Exploratory statistical procedures were used to categorize the patients into good, intermediate, and poor survival groups using the following proliferation indices as cut-points: <5%, 5–11%, and >11 %, respectively. Higher clinical stage was associated with higher MIB-1 values and shorter survival (p = 0.01, and p = 0.003, respectively). Tumor size (p = 0.02) and nodal status (p = 0.05) were also associated with higher values of MIB-1. After adjusting for age, clinical stage, nodal status, and tumor size in a multivariate analysis, MIB-1 retained its prognostic significance (p < 0.0001) when considered as either a continuous or categorical variable. There were no significant associations between MIB-1 determined proliferation index and age (p = 0.54), histologic grade (p = 0.69), nuclear grade (p = 0.06) or the presence of vascular invasion (p =.66). There is a strong statistical relationship between cell proliferative activity, as determined by MIB-1 expression, and survival in early stage breast cancer. 相似文献
90.